Relative to its peers, BSTC does not have very much institutional sponsorship. The 39.83% of shares outstanding held by institutional investors is among the least of any stock in the Pharmaceuticals: Other industry.
| Individual stakeholders | 44.23% |
| Mutual fund holders | 28.73% |
| Other institutional | 11.09% |